Strontium-89 Chloride Injection Market size was valued at USD 150 Million in 2024 and is forecasted to grow at a CAGR of 6.4% from 2026 to 2033, reaching USD 250 Million by 2033.
The South Korea Strontium-89 Chloride Injection Market is witnessing a significant surge in demand, driven by its crucial role in medical treatments, particularly for patients suffering from bone metastases due to cancer. Strontium-89 chloride, a radiopharmaceutical, is used in palliative care to help reduce bone pain and improve quality of life. The South Korean market for this product is experiencing notable growth as the healthcare sector adapts to the increasing need for more advanced treatments in oncology care. Hospitals, clinics, and specialized healthcare providers are key drivers of this market.
South Korea’s healthcare industry, one of the most advanced in the world, relies heavily on high-tech treatments like Strontium-89 Chloride Injection to manage complex conditions. As cancer rates rise and the population ages, the demand for this specific radiopharmaceutical is expected to grow, with a focus on improving patient outcomes in bone cancer therapies. Strontium-89 chloride is particularly useful in managing pain related to bone metastases, making it an essential part of the therapeutic arsenal in cancer care.
The requirement for Strontium-89 Chloride Injection from various industries, including pharmaceutical companies and hospitals, is fueled by the ongoing research and development aimed at enhancing the efficacy and safety profiles of radiopharmaceuticals. Innovations in the production and delivery methods of Strontium-89 Chloride are helping streamline its administration, making it more accessible to patients who need it the most. Additionally, the expanding adoption of advanced imaging techniques and precision medicine is likely to contribute to the growth of this market.
Moreover, South Korea’s robust healthcare infrastructure and government support for medical advancements ensure that the Strontium-89 Chloride Injection market remains a key player in the region. These injections are often delivered through intravenous administration, and healthcare providers in South Korea are increasingly integrating these treatments into their cancer care programs. With a high standard of medical expertise and patient care, the demand for Strontium-89 Chloride Injection is set to expand significantly.
As the market evolves, stakeholders in the Strontium-89 Chloride Injection market will continue to innovate to meet the growing demand, ensuring that South Korean patients receive the most effective treatments available.
Get an In-Depth Research Analysis of the South Korea Strontium-89 Chloride Injection Market Size And Forecast [2025-2032]
Q BioMed
Bio Nucleonics Inc
Yantai Dongcheng Biochemicals Co.
Ltd.
Hta Co.
Ltd
Chengdu Gaotong Isotope Co.
Ltd.
Jaco Pharmaceuticals Co
ltd
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Strontium-89 Chloride Injection Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Strontium-89 Chloride Injection Market
Bone Pain Palliation
Metastatic Bone Cancer
Multiple Myeloma
Other Oncology Uses
Hospitals
Oncology Clinics
Ambulatory Surgical Centers
Research Institutions
Intravenous Injection
Subcutaneous Injection
Sterile Solutions
Lyophilized Preparations
Direct Sales
Pharmaceutical Wholesalers
Online Pharmacies
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Strontium-89 Chloride Injection Market Research Analysis
1. Introduction of the South Korea Strontium-89 Chloride Injection Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Strontium-89 Chloride Injection Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Strontium-89 Chloride Injection Market, By Type
6. South Korea Strontium-89 Chloride Injection Market, By Application
7. South Korea Strontium-89 Chloride Injection Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Strontium-89 Chloride Injection Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/